CLOCK and neoplasm: Several studies carried out in tumors of different nature, including breast, prostate, colon, lung or liver cancer, among others, show that clock genes promoters are usually methylated (although other types of mutations have been found in tumors), and therefore silenced [231,232] along the tumor process.